Michael D. Leise

Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk

Lynn A. Fussner, Julie K. Heimbach, Chun Fan et al. · Liver Transplantation · 2015 · 201 citations

Medicine, Surgery, Hepatology +16

Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma

Amit G. Singal, Nicole E. Rich, Neil Mehta et al. · Gastroenterology · 2019 · 190 citations · Full text

Medicine, Infectious Diseases, Pharmacology +11

Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant

Surakit Pungpapong, Bashar Aqel, Michael D. Leise et al. · Hepatology · 2015 · 180 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

A Revised Model for End-Stage Liver Disease Optimizes Prediction of Mortality Among Patients Awaiting Liver Transplantation

Michael D. Leise, W. Ray Kim, Walter K. Kremers et al. · Gastroenterology · 2011 · 168 citations

Medicine, Internal Medicine, Hepatology +13

Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study

Amit G. Singal, Nicole E. Rich, Neil Mehta et al. · Gastroenterology · 2019 · 162 citations · Full text

Medicine, Oncology, Pharmacotherapy +12